Transplacental passage of the pyrimethamine-sulfadoxine combination in the prenatal treatment of congenital toxoplasmosis

Presse Medicale

Volumn 19, Issue 44, 1990, Pages 2036-

  Dorangeon, P H ^a   Fay, R ^a   Marx Chemla, C ^a   Leroux, B ^a   Harika, G ^a   Dupouy, D ^a   Quereux, C ^a   Choisy, H ^a   Pinon, J M ^a   Wahl, P ^a  

^a REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FANSIDAR; FOLINATE CALCIUM; FOLINIC ACID; PYRIMETHAMINE; SULFADOXINE;

ADULT; CLINICAL ARTICLE; CONGENITAL TOXOPLASMOSIS; FEMALE; HUMAN; LETTER; NEWBORN; ORAL DRUG ADMINISTRATION; PLACENTAL TRANSFER; PRIORITY JOURNAL; BLOOD; DRUG COMBINATION; DRUG EFFECT; FETOMATERNAL TRANSFUSION; PREGNANCY;

DRUG THERAPY, COMBINATION; FEMALE; HUMAN; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; PREGNANCY; PYRIMETHAMINE; SULFADOXINE; TOXOPLASMOSIS, CONGENITAL;

EID: 0041699112     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)